F051 Advanced Management of the Dermatologic Manifestations of Connective Tissue Diseases
DESCRIPTION
Autoimmune connective tissue diseases are complex multi-organ diseases but most have prominent cutaneous manifestations (Photosensitivity, Raynaud's, ulcerations, calcinosis cutis, itch). Although these disease components have a considerable impact on patient quality of life given they are not life-threatening, and in the domain of dermatologists, they are often under-treated by other specialists. This session, aimed at practicing medical dermatologists who may see these patients in consults, is designed to review the newest medications in these diseases, and ways to optimize management of severe or treatment resistant cases.
LEARNING OBJECTIVES
Identify common cutaneous manifestations of connective tissue diseases where dermatologists can play a role in therapy.
Formulate a plan for therapy in severe or treatment resistant cases.
List updates in the area of clinical management of autoimmune connective tissue disease dermatological manifestations.
SCHEDULE
1:00 PM
Introduction: Advanced Management Session
Gideon Smith, MD, FAAD
1:05 PM
Advanced Management of the Dermatologic Manifestations of Lupus
Benjamin F. Chong, MD, MSc, FAAD
1:40 PM
Advanced Management of the Dermatologic Manifestations of Dermatomyositis
Danielle Tartar, MD, PhD, FAAD
2:15 PM
Advanced Management of the Dermatologic Manifestations of Scleroderma
Anna Haemel, MD, FAAD
DIRECTOR
Gideon Smith, MD, FAAD
SPEAKERS
Benjamin F. Chong, MD, MSc, FAAD
Anna Haemel, MD, FAAD
Danielle Tartar, MD, PhD, FAAD
HANDOUTS
DISCLOSURES
Benjamin F. Chong, MD, MSc, FAAD
Amgen – Consultant (1099 relationship)(Honoraria); AstraZeneca – Consultant (1099 relationship)(Fees); Biogen – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Cesas Medical Limited – Speaker(Honoraria); EMD Serono – Consultant(Honoraria), Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Consultant(Honoraria); Lupus Research Alliance – Consultant (1099 relationship)(Honoraria); MAPI Research Trust – Other(Patent royalties or other compensation for Intellectual Property Rights);
Anna Haemel, MD, FAAD
AstraZeneca – Investigator(Fees); Celldex – Investigator(Grants/Research Funding); CSL Behring – Data Safety Monitoring Board(Honoraria); Eli Lilly – Stockholder Public Company(Stock); Galderma – Investigator(Grants/Research Funding); Insmed – Investigator(Fees); Priovant Therapeutics – Advisory Board(Honoraria), Investigator(Fees);
Gideon Smith, MD, FAAD
No financial relationships exist with ineligible companies.
Danielle Tartar, MD, PhD, FAAD
Priovant Therapeutics – Advisory Board(Honoraria);